Menopause and Hormone Replacement Therapy: Experts Respond to New Evidence with Hope for Women

Hormone Replacement Therapy (HRT) has come a long way to where it is today – back in the news. Once feared or misunderstood, it’s now undergoing a major rethink. Whether you’re approaching menopause, in the middle of it, or past it, recent changes in HRT could mean better care and more choices for you.

HRT replaces hormones that naturally drop during menopause (primarily estrogen and sometimes progesterone). It was used to ease symptoms like hot flashes, night sweats, mood swings, and vaginal dryness. It also helped protect against bone loss

Why WHI changed everything

People were advised against Hormone Replacement Therapy (HRT) — especially in the early 2000s — mainly because of the results from a large, influential study called the Women’s Health Initiative (WHI). Here’s a breakdown of what happened and why the advice changed:

Why People Were Warned Off HRT in the Past

The WHI Study – or Women’s Health Initiative (2002) was a turning point. It was a major government-funded study looking at the effects of HRT on postmenopausal women. Early results showed an increased risk of breast cancer, stroke, blood clots, and heart disease in women taking combined HRT (estrogen + progestin). At the time the headlines were alarming — and many women (and doctors) quickly stopped using or recommending HRT

The women in the WHI study were mostly older (average age: 63) and many were years past menopause, which is not the typical starting point for HRT.

The findings were applied broadly, even though the risks may not have applied to younger women or those using different types or doses of HRT.

Fear and Misinformation increased with the intense media coverage that made HRT sound dangerous for all women, regardless of age, health, or symptoms. Many doctors became overly cautious and stopped recommending HRT, even when it might have helped.

What We Know Now

Follow-up research has shown that the timing of HRT matters: Women who start before age 60 or within 10 years of menopause generally have more benefits and fewer risks. The type of HRT (oral vs. patch vs. local), the dose, and the individual woman’s health also play major roles. HRT is no longer seen as “bad for everyone” — it’s about personalized risk vs. benefit.

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women

Background

Hormone Replacement Therapy (HRT) has long been an important treatment option for women to alleviate symptoms of menopause, among other potential health benefits. Over the last two decades, however, HRT has been surrounded by confusing narratives about potential risks.

Last week there was a convening of an expert panel at the FDA – on July 17th – to discuss the latest evidence. You can watch that panel discussion, HERE:

When HRT was first supposed to increase the risk of cancers, it fell off the prescription recommendation – not only did it do that for the past 50 years – but it fell off the curriculum for teaching medical professionals about when and how to use this treatment for menopause and its symptoms.

People were advised against HRT because of early, broad conclusions from a single major study. Today, medical thinking has shifted — and for many women, especially younger or newly menopausal, HRT is safe, effective, and life-changing when used correctly.

New Guidelines and Attitudes

Medical groups (like The North American Menopause Society) now support earlier, more personalized use of HRT. The focus is on “the right dose, for the right woman, at the right time” Pills, patches, gels, sprays, vaginal rings, and custom-compounded creams are the various, and some new, ways of delivering the medication, which include local vs systemic therapy: Targeting symptoms with fewer side effects. More women are asking about “bioidentical” options — hormones that are chemically identical to those your body produces, and FDA-approved bioidentical versions now available (vs custom compounding)

Improved Safety Profile

New research shows that for most healthy women under age 60 and within 10 years of menopause, HRT is safe and beneficial. Lower doses are used today than in the past – much like new research led to lower doses of birth control pills, commonly used today.

Focus on Individual Risk

Providers now look more closely at personal history (e.g., cancer risk, blood clots, heart health), and increased education to the patient allows for more informed and shared decision-making.

What Hasn’t Changed

HRT is still not recommended for everyone. Risks still exist, especially for those with certain health conditions. Ongoing need for annual reviews with your doctor

Who Should Consider HRT Now?

• Women under 60, within 10 years of menopause, with moderate to severe symptoms

• Women with early menopause (before 40)

• Those at high risk for osteoporosis

What to Ask Your Doctor

• What type of HRT is right for me?

• What are the risks and benefits in my case?

• How will we monitor and adjust my treatment.

Physician and Provider Education

As medical science thought it was through with HRT, there is a generation of professionals who never received training in the appropriate prescription of HRT and medical groups will be scrambling to provide this through seminars, and advanced, required training for specialists in the field.

Today’s HRT is not one-size-fits-all. With evolving science and more flexible options, women have more power than ever to make informed choices about their hormone health. Talk to a trusted provider — and don’t settle for suffering.